Other blood-based biomarkers including the Glial Fibrillary Acidic Protein (GFAP), the Neuron-Specific Enolase (NSE), and the S100b protein have been also evaluated as prognostic factors for patients with traumatic brain injury and subarachnoid hemorrhage [21–26]. The gene discussed is GFAP; the disease is subarachnoid hemorrhage.